Non-Hodgkin's lymphomas, version 1.2013 (original) (raw)

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018

Joseph O Moore

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

View PDFchevron_right

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016

Lubomir Sokol

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

View PDFchevron_right

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma

Marcello Persico

Journal of Hepatology, 2008

View PDFchevron_right

Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines

Leo Gordon

Journal of the National Comprehensive Cancer Network, 2012

View PDFchevron_right

Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Leo Gordon

Journal of the National Comprehensive Cancer Network, 2020

View PDFchevron_right

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

Olivier Hermine

PloS one, 2016

View PDFchevron_right

Non-Hodgkin's lymphomas, version 2.2014

Lubomir Sokol

Journal of the National Comprehensive Cancer Network : JNCCN, 2014

View PDFchevron_right

Impact of Chronic HCV Infection on Treatment Outcome of Patients with Non-Hodgkin's Lymphoma

Eman abdelsameea

Journal of cancer and tumor international, 2018

View PDFchevron_right

Update on epidemiology and therapeutics for non-Hodgkin's lymphoma

Janet Dancey

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2002

View PDFchevron_right

HCV infection, B-cell non-Hodgkin’s lymphoma and immunochemotherapy: Evidence and open questions

Eleonora Alma

World Journal of Gastrointestinal Oncology, 2012

View PDFchevron_right

Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment

Gabriele Pozzato

Clinics in liver disease, 2017

View PDFchevron_right

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Joseph O Moore

Journal of The National Comprehensive Cancer Network, 2017

View PDFchevron_right

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma

Lubomir Sokol

Cancer control : journal of the Moffitt Cancer Center

View PDFchevron_right

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017

Thomas Habermann

Journal of the National Comprehensive Cancer Network, 2017

View PDFchevron_right

Primary refractory Hodgkin lymphoma: Limited options and poor survival-but not always

Jorge Castillo

American Journal of Hematology, 2014

View PDFchevron_right

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma

Adriano Pellicelli

Clinical and Experimental Hepatology, 2018

View PDFchevron_right

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

Olivier Hermine

American Journal of Hematology, 2014

View PDFchevron_right

Hepatitis C Virus and non-Hodgkin’s lymphomas: A minireview

H. Khalid

Journal of Advanced Research, 2017

View PDFchevron_right

Fifteenth Biannual Report of the Cochrane Haematological Malignancies Group--Focus on Non-Hodgkin's Lymphoma

Nicole Skoetz

JNCI Journal of the National Cancer Institute, 2013

View PDFchevron_right

Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma

Ludovico Abenavoli

Hepatology, 2017

View PDFchevron_right

Aggressive non-Hodgkin’s lymphoma – long-term survival for all patients?

Jacques Tabacof

Hematology Meeting Reports, 2009

View PDFchevron_right

Non-Hodgkin's lymphomas, version 4.2014

Lubomir Sokol

Journal of the National Comprehensive Cancer Network : JNCCN, 2014

View PDFchevron_right

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

B. Vannata

Hematology, 2014

View PDFchevron_right

Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis

Ricardo Moreno-Otero

Gastroenterology, 2003

View PDFchevron_right

Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study

ANASTASIA ANASTASOPOULOU

JNCI Journal of the National Cancer Institute, 2001

View PDFchevron_right

Non-Hodgkin Lymphoma and Hepatitis C: Where We are and What Next?

Mihály Makara

Pathology & Oncology Research, 2014

View PDFchevron_right

Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches

Narendranath Epperla

Experimental Hematology & Oncology

View PDFchevron_right

Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma

Nicole Skoetz

J Natl Cancer Inst, 2014

View PDFchevron_right